In support of this, we found that the SIM2 peptide, corresponding to the C-terminal SIM of DAXX, inhibits de novo lipogenesis and suppresses in vivo tumor growth (Fig. 8 and Supplementary Fig. S12). This evidence concerns the gene SIM2 and neoplasm.